An Institutional Review Board (IRB) is an independent committee established to review and approve research involving human subjects. The primary purpose of an IRB is to protect the rights, safety, and well-being of individuals participating in clinical trials or other research studies.
IRBs are responsible for evaluating research protocols, informed consent documents, and other study-related materials to ensure ethical conduct and compliance with regulations. They have the authority to approve, require modifications to, or disapprove research projects based on their assessment of potential risks and benefits to study participants.
The term 'IRB’ is crucial in clinical research because it represents the primary safeguard for human subjects participating in studies. IRBs play a vital role in ensuring that research protocols adhere to ethical standards and regulatory requirements, which is essential for maintaining the integrity and credibility of clinical trials.
Understanding the function and importance of IRBs is critical for researchers, sponsors, and study coordinators involved in clinical studies. IRB approval is a mandatory step in the research process, and familiarity with IRB procedures and expectations can significantly streamline the study initiation process and help maintain compliance throughout the duration of a clinical trial.
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
Copyright @ 2026 Axcellant